The first case report of sulfonylurea use in a woman with permanent neonatal diabetes mellitus due to KCNJ11 mutation during a high-risk pregnancy

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 3599-3604

  Klupa, Tomasz ^a,b   Kozek, Elzbieta ^a,b   Nowak, Natalia ^a   Cyganek, Katarzyna ^a,b   Gach, Agnieszka ^c,d   Milewicz, Tomasz ^e   Czajkowski, Krzysztof ^f   Tolloczko, Justyna ^f   Mlynarski, Wojciech ^c   Malecki, Maciej T ^a,b  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY HOSPITAL IN KRAKOW   (Poland)

^c MEDICAL UNIVERSITY OF LODZ   (Poland)

^d POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

^e JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^f MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHORIONIC GONADOTROPIN; DYDROGESTERONE; GLIBENCLAMIDE; GLIPIZIDE; GLUCOSE; HEMOGLOBIN A1C; HYDROXYPROGESTERONE CAPROATE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; ISOPHANE INSULIN; METHYLDOPA; PREGNANCY ASSOCIATED PLASMA PROTEIN A; PROTEIN; SULFONYLUREA; THIAZIDE DIURETIC AGENT;

ADULT; APPENDECTOMY; APPENDICITIS; ARTICLE; AUTONOMIC NEUROPATHY; BREECH PRESENTATION; CARDIOTOCOGRAPHY; CARPAL TUNNEL SYNDROME; CASE REPORT; CESAREAN SECTION; DIABETES MELLITUS; DRUG DOSE INCREASE; ECHOGRAPHY; FEMALE; FETUS HEART RATE; GENE MUTATION; GENETIC SCREENING; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; GYNECOLOGICAL EXAMINATION; HORMONAL THERAPY; HUMAN; HYPERBILIRUBINEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPOGLYCEMIA; HYSTEROSCOPY; INSULIN INFUSION; INSULIN PUMP; INSULIN TREATMENT; LOW LEVEL LASER THERAPY; MICROALBUMINURIA; NEWBORN; PERIPHERAL EDEMA; PHOTOTHERAPY; POLYNEUROPATHY; PREGNANCY; PRIORITY JOURNAL; PROLIFERATIVE RETINOPATHY; PROTEIN URINE LEVEL; PROTEINURIA; SACRUM; TACHYCARDIA; TACHYPNEA; TRANSVAGINAL ECHOGRAPHY; TRISOMY 21; UTERUS BICORNIS;

EID: 77955358841     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0096     Document Type: Article

References (29)

1. Murphy R, Ellard S, Hattersley AT 2008 Clinical implications of a molecular genetic classification of monogenic β-cell diabetes. Nat Clin Pract Endocrinol Metab 4:200-213 (Pubitemid 351430925)
2. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, Slingerland AS, Howard N, Srinivasan S, Silva JM, Molnes J, Edghill EL, Frayling TM, Temple IK, Mackay D, Shield JP, Sumnik Z, van Rhijn A, Wales JK, Clark P, Gorman S, Aisenberg J, Ellard S, Njølstad PR, Ashcroft FM, Hattersley AT 2004 Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 350:1838-1849 (Pubitemid 38917250)
3. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P 2006 Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355:456-466 (Pubitemid 44162273)
4. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, Slingerland AS, Shield J, Robert JJ, Holst JJ, Clark PM, Ellard S, Søvik O, Polak M, Hattersley AT; Neonatal Diabetes International Collaborative Group 2006 Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355:467-477
5. Rafiq M, Flanagan SE, Patch AM, Shields BM, Ellard S, Hattersley AT; Neonatal Diabetes International Collaborative Group 2008 Effective treatment with oral sulfonylureas in patients with diabetes due to sulfonylurea receptor 1 (SUR1) mutations. Diabetes Care 31:204-209 (Pubitemid 351213320)
6. Begum-Hasan J, Polychronakos C, Brill H 2008 Familial permanent neonatal diabetes with KCNJ11 mutation and the response to glyburide therapy - a three-year follow-up. J Pediatr Endocrinol Metab 21:895-903
7. Klupa T, Skupien J, Mirkiewicz-Sieradzka B, Gach A, Noczynska A, Zubkiewicz-Kucharska A, Szalecki M, Kozek E, Nazim J, Mlynarski W, Malecki MT 2010 Efficacy and safety of sulphonylurea use in permanent neonatal diabetes due to KCNJ11 gene mutations: 34-month median follow-up. Diabetes Technol Ther 12:387-391
8. Klupa T, Edghill EL, Nazim J, Sieradzki J, Ellard S, Hattersley AT, Malecki MT 2005 The identification of a R201H mutation in KCNJ11, which encodes Kir6.2, and successful transfer to sustained-release sulphonylurea therapy in a subject with neonatal diabetes: evidence for heterogeneity of β-cell function among carriers of the R201H mutation. Diabetologia 48:1029-1031 (Pubitemid 40767999)
9. Malecki MT, Skupien J, Klupa T, Wanic K, Mlynarski W, Gach A, Solecka I, Sieradzki J 2007 Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating mutations: evidence for improvement in insulin sensitivity. Diabetes Care 30:147-149 (Pubitemid 46052514)
10. Zung A, Glaser B, Nimri R, Zadik Z 2004 Glibenclamide treatment in permanent neonatal diabetes mellitus due to an activating mutation in Kir6.2. J Clin Endocrinol Metab 89:5504-5507 (Pubitemid 39518433)
11. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT 2006 Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 49:1190-1197
12. Mlynarski W, Tarasov AI, Gach A, Girard CA, Pietrzak I, Zubcevic L, Kusmierek J, Klupa T, Malecki MT, Ashcroft FM 2007 Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11. Nat Clin Pract Neurol 3:640-645 (Pubitemid 350048230)
13. Slingerland AS, Nuboer R, Hadders-Algra M, Hattersley AT, Bruining GJ 2006 Improved motor development and good long-term glycaemic control with sulfonylurea treatment in a patient with the syndrome of intermediate developmental delay, early-onset generalised epilepsy and neonatal diabetes associated with the V59M mutation in the KCNJ11 gene. Diabetologia 49:2559-2563
14. Kumaraguru J, Flanagan SE, Greeley SA, Nuboer R, Støy J, Philipson LH, Hattersley AT, Rubio-Cabezas O 2009 Tooth discoloration in patients with neonatal diabetes after transfer onto glibenclamide: a previously unreported side effect. Diabetes Care 32:1428-1430
15. Klupa T, Skupien J, Mirkiewicz-Sieradzka B, Gach A, Noczynska A, Szalecki M, Kozek E, Sieradzki J, Mlynarski W, Malecki MT 2009 Diabetic retinopathy in permanent neonatal diabetes due to Kir6.2 gene mutations: the results of a minimum 2-year follow-up after the transfer from insulin to sulphonylurea. Diabet Med 26:663-664
16. Kitzmiller JL, Block JM, Brown FM, Catalano PM, Conway DL, Coustan DR, Gunderson EP, Herman WH, Hoffman LD, Inturrisi M, Jovanovic LB, Kjos SI, Knopp RH, Montoro MN, Ogata ES, Paramsothy P, Reader DM, Rosenn BM, Thomas AM, Kirkman MS 2008 Managing preexisting diabetes for pregnancy: summary of evidence and consensus recommendations for care. Diabetes Care 31:1060-1079
17. Howorka K, Pumprla J, Gabriel M, Feiks A, Schlusche C, Nowotny C, Schober E, Waldhoer T, Langer M 2001 Normalization of pregnancy outcome in pregestational diabetes through functional insulin treatment and modular out-patient education adapted for pregnancy. Diabet Med 18:965-972 (Pubitemid 34042932)
18. Casson IF, Clarke CA, Howard CV, McKendrick O, Pennycook S, Pharoah PO, Platt MJ, Stanisstreet M, van Velszen D, Walkinshaw S 1997 Outcomes of pregnancy in insulin dependent diabetic women: results of a five year population cohort study. BMJ 315:275-278 (Pubitemid 27326208)
19. Tallarigo L, Giampietro O, Penno G, Miccoli R, Gregori G, Navalesi R 1986 Relation of glucose tolerance to complications of pregnancy in nondiabetic women. N Engl J Med 315:989-992 (Pubitemid 16028579)
20. Landon MB, Spong CY, Thom E, Carpenter MW, Ramin SM, Casey B, Wapner RJ, Varner MW, Rouse DJ, Thorp Jr JM, Sciscione A, Catalano P, Harper M, Saade G, Lain KY, Sorokin Y, Peaceman AM, Tolosa JE, Anderson GB 2009 A multicenter, randomized trial of treatment for mild gestational diabetes. N Engl J Med 361:1339-1348
21. Langer O, Conway DL, Berkus MD, Xenakis EM, Gonzales O 2000 A comparison of glyburide and insulin in women with gestational diabetes mellitus. N Engl J Med 343:1134-1138
22. Gimeno-Orna JA, Castro-Alonso FJ, Boned-Juliani B, Lou-Arnal LM 2003 Fasting plasma glucose variability as a risk factor of retinopathy in type 2 diabetic patients. J Diabetes Complications 17:78-81 (Pubitemid 36279504)
23. Kilpatrick ES, Rigby AS, Atkin SL 2009 Effect of glucose variability on the long-term risk of microvascular complications in type 1 diabetes. Diabetes Care 32:1901-1903
24. Garcia-Bournissen F, Feig DS, Koren G 2003 Maternal-fetal transport of hypoglycaemic drugs. Clin Pharmacokinet 42:303-313
25. Hebert MF, Ma X, Naraharisetti SB, Krudys KM, Umans JG, Hankins GD, Caritis SN, Miodovnik M, Mattison DR, Unadkat JD, Kelly EJ, Blough D, Cobelli C, Ahmed MS, Snodgrass WR, Carr DB, Easterling TR, Vicini P; Obstetric-Fetal Pharmacology Research Unit Network 2009 Are we optimizing gestational diabetes treatment with glyburide? The pharmacologic basis for better clinical practice. Clin Pharmacol Ther 85:607-614
26. Moretti ME, Rezvani M, Koren G 2008 Safety of glyburide for gestational diabetes: a meta-analysis of pregnancy outcomes. Ann Pharmacother 42:483-490
27. Nicholson W, Bolen S, Witkop CT, Neale D, Wilson L, Bass E 2009 Benefits and risks of oral diabetes agents compared with insulin in women with gestational diabetes: a systematic review. Obstet Gynecol 113:193-205
28. Garg M, Devaskar SU 2006 Glucose metabolism in the late preterm infant. Clin Perinatol 33:853-870; abstract ix-x
29. Domènech E, Kruyer H, Gómez C, Calvo MT, Nunes V 2004 First prenatal diagnosis for Wolfram syndrome by molecular analysis of the WFS1 gene. Prenat Diagn 24:787-789